Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CALL
Booking.com
BKNG
$161B
| $396K | ﹤0.01% |
2,500
| – | – |
|
3077
American Vanguard Corp
AVD
$68.9M
| $395K | ﹤0.01% |
45,883
-23,535
| -34% | -$241K |
|
3078
Business First Bancshares
BFST
$1.03B
| $394K | ﹤0.01% |
18,129
-12,785
| -41% | -$267K |
|
|
SILK
3079
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $394K | ﹤0.01% |
14,569
-22,929
| -61% | -$477K |
|
3080
AdaptHealth
AHCO
$759M
| $393K | ﹤0.01% |
39,291
-42,796
| -52% | -$435K |
|
3081
Domo
DOMO
$184M
| $392K | ﹤0.01% |
50,773
-739
| -1% | -$5.53K |
|
3082
Wolverine World Wide
WWW
$1.55B
| $391K | ﹤0.01% |
28,926
-41,434
| -59% | -$498K |
|
3083
Lifestance Health
LFST
$4.14B
| $389K | ﹤0.01% |
79,310
-32,699
| -29% | -$197K |
|
3084
Xeris Biopharma Holdings
XERS
$1.37B
| $389K | ﹤0.01% |
172,787
-32,186
| -16% | -$64.9K |
|
3085
Sturm, Ruger & Co
RGR
$593M
| $388K | ﹤0.01% |
9,327
-10,712
| -53% | -$475K |
|
|
SMLR
3086
DELISTED
Semler Scientific
SMLR
| $388K | ﹤0.01% |
11,290
+7,977
| +241% | +$230K |
|
3087
Regional Management Corp
RM
$303M
| $388K | ﹤0.01% |
13,506
-3,405
| -20% | -$92.2K |
|
3088
Meridian
MRBK
$234M
| $386K | ﹤0.01% |
36,731
| – | – |
|
|
SHOE
3089
Shoe Station Group
SHOE
$428M
| $386K | ﹤0.01% |
10,474
-8,509
| -45% | -$302K |
|
3090
BlackBerry
BB
$5.26B
| $386K | ﹤0.01% |
155,567
-89,548
| -37% | -$250K |
|
3091
Alphatec Holdings
ATEC
$1.44B
| $386K | ﹤0.01% |
36,893
-46,871
| -56% | -$546K |
|
3092
United Fire Group
UFCS
$1.4B
| $385K | ﹤0.01% |
17,911
-7,866
| -31% | -$174K |
|
3093
Anavex Life Sciences
AVXL
$310M
| $384K | ﹤0.01% |
91,078
-21,174
| -19% | -$85.6K |
|
|
SRTA
3094
Strata Critical Medical Inc
SRTA
$512M
| $383K | ﹤0.01% |
110,075
-40,651
| -27% | -$136K |
|
|
TPC
3095
Tutor Perini Cor
TPC
$5.21B
| $382K | ﹤0.01% |
17,556
-28,851
| -62% | -$530K |
|
3096
Vanda Pharmaceuticals
VNDA
$302M
| $382K | ﹤0.01% |
67,620
-58,056
| -46% | -$300K |
|
3097
CALL
Archer Daniels Midland
ADM
$36.9B
| $381K | ﹤0.01% |
6,300
-45,700
| -88% | -$2.8M |
|
3098
CALL
Freshworks
FRSH
$3.27B
| $381K | ﹤0.01% |
+30,000
| New | +$449K |
|
|
CHCT
3099
Community Healthcare Trust
CHCT
$454M
| $380K | ﹤0.01% |
16,228
-13,889
| -46% | -$338K |
|
3100
Weis Markets
WMK
$1.86B
| $379K | ﹤0.01% |
6,041
-9,057
| -60% | -$578K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.